Siguo Hao

2.3k total citations
62 papers, 1.7k citations indexed

About

Siguo Hao is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Siguo Hao has authored 62 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Immunology, 28 papers in Molecular Biology and 23 papers in Oncology. Recurrent topics in Siguo Hao's work include Immunotherapy and Immune Responses (27 papers), Extracellular vesicles in disease (15 papers) and Immune Cell Function and Interaction (14 papers). Siguo Hao is often cited by papers focused on Immunotherapy and Immune Responses (27 papers), Extracellular vesicles in disease (15 papers) and Immune Cell Function and Interaction (14 papers). Siguo Hao collaborates with scholars based in China, Canada and United States. Siguo Hao's co-authors include Jim Xiang, Jinying Yuan, Ou Bai, Liyuan Ma, Jiangbo Wan, Mabood Qureshi, Suzanne Laferté, Fang Huang, Fang Li and Linjun Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, The EMBO Journal and Blood.

In The Last Decade

Siguo Hao

59 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Siguo Hao China 25 1.1k 764 457 452 144 62 1.7k
Elena Provasi Italy 14 1.1k 0.9× 505 0.7× 342 0.7× 682 1.5× 60 0.4× 22 2.0k
Jasper H. N. Yik United States 20 1.9k 1.7× 403 0.5× 207 0.5× 260 0.6× 221 1.5× 48 2.8k
Monika C. Wolkers Netherlands 27 842 0.7× 1.6k 2.1× 326 0.7× 885 2.0× 56 0.4× 63 2.6k
Cristina Bergamaschi United States 22 685 0.6× 1.1k 1.4× 313 0.7× 416 0.9× 40 0.3× 39 1.9k
Christian M. Capitini United States 23 530 0.5× 702 0.9× 135 0.3× 670 1.5× 182 1.3× 87 1.7k
Aleksandar Dakic Australia 14 871 0.8× 1.2k 1.5× 296 0.6× 667 1.5× 312 2.2× 18 2.2k
Dori A. Thomas United States 9 787 0.7× 1.2k 1.5× 192 0.4× 885 2.0× 105 0.7× 9 2.0k
Patrick H. Lizotte United States 16 499 0.4× 548 0.7× 350 0.8× 685 1.5× 53 0.4× 32 1.7k
Yufeng Xie China 23 1.0k 0.9× 620 0.8× 466 1.0× 264 0.6× 33 0.2× 58 1.6k
Deborah J. Burt United Kingdom 17 368 0.3× 655 0.9× 281 0.6× 985 2.2× 88 0.6× 24 1.6k

Countries citing papers authored by Siguo Hao

Since Specialization
Citations

This map shows the geographic impact of Siguo Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siguo Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siguo Hao more than expected).

Fields of papers citing papers by Siguo Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siguo Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siguo Hao. The network helps show where Siguo Hao may publish in the future.

Co-authorship network of co-authors of Siguo Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Siguo Hao. A scholar is included among the top collaborators of Siguo Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siguo Hao. Siguo Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Yan, et al.. (2025). Inhibition of Galectin-3 Expression Could Preserve the Immunoregulatory Function of Mesenchymal Stem Cells During Cell Passaging. Frontiers in Bioscience-Landmark. 30(8). 39918–39918. 1 indexed citations
3.
Tao, Rong, Chuanxu Liu, Wenhao Zhang, et al.. (2023). Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 Blockade. The Oncologist. 29(1). e90–e96. 5 indexed citations
4.
Brunner, Hermine I., Gerd Horneff, Ivan Foeldvari, et al.. (2023). OP0164 SAFETY AND EFFICACY OF UPADACITINIB FOR PEDIATRIC PATIENTS WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS: AN INTERIM ANALYSIS OF AN OPEN-LABEL, PHASE 1 TRIAL. Annals of the Rheumatic Diseases. 82. 108–109. 2 indexed citations
5.
Li, Jiaqi, Fang Huang, Yan Jiang, et al.. (2022). A novel costimulatory molecule gene-modified leukemia cell-derived exosome-targeted CD4+ T cell vaccine efficiently enhances anti-leukemia immunity. Frontiers in Immunology. 13. 1043484–1043484. 8 indexed citations
6.
Song, Yuqin, Yanyan Liu, Zhiming Li, et al.. (2022). SHR2554, an EZH2 inhibitor, in relapsed or refractory mature lymphoid neoplasms: a first-in-human, dose-escalation, dose-expansion, and clinical expansion phase 1 trial. The Lancet Haematology. 9(7). e493–e503. 32 indexed citations
7.
Zhang, Youping, Ting Luo, Xinyu Ding, et al.. (2021). Inhibition of mitochondrial complex III induces differentiation in acute myeloid leukemia. Biochemical and Biophysical Research Communications. 547. 162–168. 11 indexed citations
8.
Wan, Jiangbo, Fang Huang, Weiwei Hu, & Siguo Hao. (2018). IL-10 gene-modified dendritic cells-induced type 1 T regulatory cells inhibit graft-versus-host disease while preserving graft-versus-leukemia effect. Biochemical and Biophysical Research Communications. 507(1-4). 122–127. 2 indexed citations
9.
Wei, Wei, Chuanxu Liu, Lili Song, et al.. (2016). Targeting peroxiredoxin I potentiates 1,25-dihydroxyvitamin D3-induced cell differentiation in leukemia cells. Molecular Medicine Reports. 13(3). 2201–2207. 5 indexed citations
10.
Ma, Liyuan, Siguo Hao, Colin Phipps Diong, et al.. (2014). WPSS is a strong prognostic indicator for clinical outcome of allogeneic transplant for myelodysplastic syndrome in Southeast Asian patients. Annals of Hematology. 94(5). 761–769. 1 indexed citations
11.
Yang, Hui, et al.. (2012). Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemia. International Journal of Hematology. 96(1). 65–73. 18 indexed citations
12.
Hao, Siguo, Jinying Yuan, Shulin Xu, et al.. (2008). Antigen Specificity Acquisition of Adoptive CD4+ Regulatory T Cells via Acquired Peptide-MHC Class I Complexes. The Journal of Immunology. 181(4). 2428–2437. 16 indexed citations
13.
Ye, Zhenmin, Hui Huang, Siguo Hao, et al.. (2007). IL-10 Has A Distinct Immunoregulatory Effect on Naive and Active T Cell Subsets. Journal of Interferon & Cytokine Research. 27(12). 1031–1038. 30 indexed citations
14.
Hao, Siguo, Yongqing Liu, Jinying Yuan, et al.. (2007). Novel Exosome-Targeted CD4+ T Cell Vaccine Counteracting CD4+25+ Regulatory T Cell-Mediated Immune Suppression and Stimulating Efficient Central Memory CD8+ CTL Responses. The Journal of Immunology. 179(5). 2731–2740. 64 indexed citations
15.
Hao, Siguo, Terence Moyana, & Jim Xiang. (2007). Review: Cancer Immunotherapy by Exosome-Based Vaccines. Cancer Biotherapy and Radiopharmaceuticals. 22(5). 692–703. 56 indexed citations
16.
Hao, Siguo, Zhenmin Ye, Jicheng Yang, Ou Bai, & Jim Xiang. (2006). Intradermal Vaccination of Dendritic Cell–Derived Exosomes Is Superior to a Subcutaneous One in the Induction of Antitumor Immunity. Cancer Biotherapy and Radiopharmaceuticals. 21(2). 146–154. 23 indexed citations
17.
Xia, Dajing, Siguo Hao, & Jim Xiang. (2006). CD8+ Cytotoxic T-APC Stimulate Central Memory CD8+ T Cell Responses via Acquired Peptide-MHC Class I Complexes and CD80 Costimulation, and IL-2 Secretion. The Journal of Immunology. 177(5). 2976–2984. 37 indexed citations
18.
Shi, Meiqing, Siguo Hao, Liping Su, et al.. (2005). Vaccine of Engineered Tumor Cells Secreting Stromal Cell–Derived Factor-1 Induces T-Cell Dependent Antitumor Responses. Cancer Biotherapy and Radiopharmaceuticals. 20(4). 401–409. 9 indexed citations
19.
Shi, Meiqing, et al.. (2005). Significant Tumor Regression Induced by Microencapsulation of Recombinant Tumor Cells Secreting Fusion Protein. Cancer Biotherapy and Radiopharmaceuticals. 20(3). 260–266. 7 indexed citations
20.
Hao, Siguo, et al.. (2005). Molecular and Immunophenotypical Characterization of Progressive and Regressive Leukemia Cell Lines. Cancer Biotherapy and Radiopharmaceuticals. 20(3). 290–299.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026